Hester Biosciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
HESTERBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hester Biosciences has informed the exchanges that its trading window for dealing in equity shares will be closed starting 1 January 2026. The window will reopen 48 hours after the company's financial results for the quarter and nine months ended 31 December 2025 are made public. This is a standard compliance measure under SEBI's insider trading regulations, restricting directors, promoters, designated employees, and connected persons from trading in the stock during this period. The closure typically signals that quarterly earnings announcement is due soon.
No direct impact on shareholders or stock price. This is a routine regulatory filing. Investors can expect the Q3 FY26 results to be released sometime after 1 January 2026, which may be the next material catalyst for the stock.